
Korean medical advertising rules
Korean laws that limit what hospitals and clinics may say when they advertise treatments.
Korea’s Medical Service Act bans several kinds of medical advertising, including false content, exaggerated claims, patient testimonials that could mislead about results, comparisons with or attacks on other providers, leaving out serious side effects, and advertising new health technologies that have not been assessed. Some advertising must be reviewed before it runs.
Separate rules apply to advertising aimed at international patients: registered clinics may advertise in foreign languages in certain places, but not with before-and-after photos or other content that could mislead. The Advanced Regenerative Bio Act also bans false or exaggerated claims about regenerative treatments and cell storage.
Practical check: treat testimonials, before-and-after photos, rankings and promised results as warning signs, and ask the clinic for the evidence behind any claim.
Related terms
- New health technology assessment
- Korea’s government review of whether a newly developed medical procedure is safe and effective for a defined use.
- Registration for attracting foreign patients
- The government registration Korean hospitals, clinics and agencies need before they attract international patients.
- Advanced Regenerative Bio Act
- Korea’s main law on regenerative treatments that use human cells, and on medicines made from cells, genes or engineered tissue.
- Certainty of evidence (GRADE)
- A rating of how confident researchers are that a finding is close to the truth, usually graded high, moderate, low or very low using GRADE.
Source: Medical Service Act (Korean, Korea Law Information Center)
Read next
Not sure where to start?
Send your question and any X-ray or MRI report you have. COMEDI, the registered coordinator that runs this guide, replies in writing and can ask a clinic for its written answer and an itemised quote.